These results were supported by the fact that abnormal activation of the ATM–CHK2 pathway had been associated with resistance to chemoradiotherapy and poor prognosis in nasal extranodal NK/T cell lymphoma [32]. The gene discussed is CHEK2; the disease is extranodal nasal NK/T cell lymphoma.